New drug combo aims to control Hard-to-Treat leukemia
NCT ID NCT05038592
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This study tests a combination of two drugs—tagraxofusp and decitabine—in people with chronic myelomonocytic leukemia or high-risk myelodysplastic syndromes. Tagraxofusp is a targeted therapy that delivers a toxin to cancer cells, while decitabine is a chemotherapy drug. The trial aims to find the safest dose and see if the combination can shrink or control the cancer. It includes 64 adults whose disease has not responded well to standard treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tagraxofusp and decitabine
- What this could lead to
- If this combination works, it could offer a new treatment option for people with certain blood cancers that are hard to treat.
- What could go wrong
- This is an early-phase trial with only 64 participants, so results may not apply to everyone. The drugs can cause serious side effects, and the treatment may not shrink tumors in all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill keep blood cancer at bay after a stem cell transplant?
- Can a Two-Drug combo tame a rare blood cancer?
- Can a 'Universal' cancer target outsmart resistant blood cancers?
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Can a new oral drug take on hard-to-treat leukaemia?
- Can a new pill take on Hard-to-Treat leukemia?